For citations:
Zhukova LG, Khatkova EI, Feoklistova PS, Grechukhina KS, Smolin SA, Arutyunyan EA, Kolyago EM. Role of palbociclib in the treatment of hormone receptor-positive HER2-negative metastatic breast cancer. Generalizing results of randomized trials and real clinical practice. Meditsinskiy sovet = Medical Council. 2019;(10):56-62. (In Russ.) https://doi.org/10.21518/2079-701X-2019-10-56-62